Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells. [electronic resource]
Producer: 20041109Description: 327-34 p. digitalISSN:- 1535-7163
- Acetophenones -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis
- Benzopyrans -- pharmacology
- Blotting, Western
- Carcinoma, Small Cell
- Caspase 3
- Caspase 9
- Caspases -- metabolism
- Cell Death
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Down-Regulation
- Drug Resistance, Neoplasm
- Enzyme Activation
- Enzyme Inhibitors -- pharmacology
- Etoposide -- pharmacology
- Flow Cytometry
- Humans
- Immunoblotting
- Lung Neoplasms -- pathology
- Membrane Potentials
- Mitochondria -- pathology
- Paclitaxel -- pharmacology
- Phosphorylation
- Poly(ADP-ribose) Polymerases -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- biosynthesis
- Reverse Transcriptase Polymerase Chain Reaction
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.